CN Stock MarketDetailed Quotes

300519 Zhejiang Xinguang Pharmaceutical

Watchlist
  • 14.18
  • +2.17+18.07%
Market Closed Sep 30 15:00 CST
2.27BMarket Cap44.17P/E (TTM)

Zhejiang Xinguang Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-1.90%146.21M
8.94%100.55M
-23.07%270.4M
-17.66%216.11M
-12.57%149.04M
-9.42%92.3M
9.54%351.49M
6.57%262.45M
6.87%170.46M
6.01%101.9M
Operating revenue
-1.90%146.21M
8.94%100.55M
-23.07%270.4M
-17.66%216.11M
-12.57%149.04M
-9.42%92.3M
9.54%351.49M
6.57%262.45M
6.87%170.46M
6.01%101.9M
Other operating revenue
5.26%57.5K
----
-1.33%114.97K
----
-0.40%54.63K
----
8.28%116.52K
----
7.12%54.84K
----
Total operating cost
13.42%121.64M
31.49%76.15M
-11.51%203.77M
-5.74%151.12M
4.64%107.24M
9.46%57.91M
18.03%230.27M
10.66%160.33M
8.10%102.49M
3.64%52.91M
Operating cost
21.98%96.5M
39.32%62.81M
-6.17%158.8M
-1.20%118.61M
1.99%79.11M
3.32%45.09M
19.07%169.23M
15.58%120.04M
16.18%77.57M
14.27%43.64M
Operating tax surcharges
38.40%2.33M
45.75%1.65M
2.40%4.36M
-23.28%2.37M
-13.20%1.68M
-5.35%1.13M
0.85%4.26M
-1.98%3.08M
-3.77%1.94M
-1.46%1.19M
Operating expense
-10.27%11.47M
9.47%5.96M
-21.59%26.45M
-13.35%18.36M
-12.31%12.78M
-18.27%5.45M
5.23%33.74M
-1.22%21.18M
-2.14%14.57M
-0.53%6.66M
Administration expense
-5.37%8.24M
-7.16%3.68M
3.84%17.92M
2.13%13.09M
0.74%8.71M
2.38%3.96M
-12.63%17.26M
-3.56%12.82M
-1.27%8.65M
-1.81%3.87M
Financial expense
-41.97%-3.86M
-46.56%-1.89M
-93.45%-18.89M
-54.12%-13.07M
64.32%-2.72M
79.92%-1.29M
41.16%-9.77M
-34.18%-8.48M
-89.33%-7.61M
-169.55%-6.42M
-Interest Income (Financial expense)
-41.80%-3.86M
-46.48%-1.89M
----
-54.07%-13.08M
64.24%-2.72M
79.89%-1.29M
----
-34.11%-8.49M
-89.15%-7.62M
-169.29%-6.42M
Research and development
-9.35%6.96M
10.17%3.95M
-2.67%15.13M
0.75%11.76M
4.08%7.67M
-9.71%3.58M
15.01%15.55M
23.55%11.68M
15.14%7.37M
16.75%3.97M
Credit Impairment Loss
-100.33%-1.98K
-84.93%121.76K
263.74%708.14K
262.69%367.11K
522.28%604.9K
150.00%808.08K
-366.27%-432.48K
-31.76%-225.65K
-39.99%97.21K
-14.55%323.23K
Asset Impairment Loss
67.37%-197.91K
-65.27%-377.44K
-153.43%-503.34K
-6.51%-483.94K
-160.57%-606.47K
-590.06%-228.37K
68.20%-198.61K
-75.57%-454.36K
27.54%-232.75K
75.09%-33.09K
Other net revenue
7.64%3.81M
10.20%1.62M
39.40%7.51M
33.85%5.08M
1.77%3.54M
9.91%1.47M
-20.77%5.38M
-34.83%3.8M
49.86%3.48M
68.15%1.33M
Invest income
22.90%2.49M
109.15%1.1M
-5.63%4.07M
3.78%3.17M
-18.42%2.03M
-13.19%523.93K
-32.75%4.32M
-39.40%3.06M
61.38%2.48M
517.74%603.53K
Asset deal income
-621.97%-67.85K
-621.97%-67.85K
---290.57K
--13K
--13K
--13K
----
----
----
----
Other revenue
5.71%1.59M
141.02%844.2K
106.96%3.52M
41.86%2.01M
32.89%1.5M
-20.57%350.26K
9.42%1.7M
17.42%1.42M
20.10%1.13M
-2.14%440.96K
Operating profit
-37.39%28.38M
-27.45%26.01M
-41.45%74.13M
-33.84%70.08M
-36.55%45.33M
-28.76%35.85M
-4.51%126.6M
-1.21%105.92M
6.63%71.45M
9.72%50.32M
Add:Non operating Income
3,662.18%300.97K
2,255.93%188.47K
123.09%31.24K
-42.88%8K
-42.88%8K
-42.88%8K
-60.34%14.01K
-60.34%14.01K
-60.34%14.01K
--14.01K
Less:Non operating expense
--6.7K
--6.7K
-1.06%1M
-1.47%1M
----
----
53.46%1.01M
-73.55%1.01M
--14.94K
--1.04K
Total profit
-36.75%28.68M
-26.96%26.19M
-41.75%73.16M
-34.15%69.09M
-36.54%45.34M
-28.76%35.86M
-4.82%125.6M
1.46%104.92M
6.57%71.45M
9.74%50.34M
Less:Income tax cost
-53.41%3.17M
-37.93%3.36M
-47.54%8.8M
-33.09%10.39M
-36.09%6.8M
-28.00%5.41M
-5.06%16.78M
0.56%15.52M
6.16%10.65M
9.17%7.52M
Net profit
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
9.85%42.82M
Net profit from continuing operation
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
9.85%42.82M
Net profit of parent company owners
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
9.85%42.82M
Earning per share
Basic earning per share
-33.33%0.16
-26.32%0.14
-41.18%0.4
-33.93%0.37
-36.84%0.24
-29.63%0.19
-4.23%0.68
1.82%0.56
5.56%0.38
12.50%0.27
Diluted earning per share
-33.33%0.16
-26.32%0.14
-41.18%0.4
-33.93%0.37
-36.84%0.24
-29.63%0.19
-4.23%0.68
1.82%0.56
5.56%0.38
12.50%0.27
Other composite income
-169.19%-231.39K
-404.10%-407.24K
705.96%869.74K
240.11%429.7K
10,126.03%334.44K
-35.17%133.92K
-140.55%-143.53K
-562.59%-306.68K
-101.99%-3.34K
67.03%206.55K
Other composite income of parent company owners
-169.19%-231.39K
-404.10%-407.24K
705.96%869.74K
240.11%429.7K
10,126.03%334.44K
-35.17%133.92K
-140.55%-143.53K
-562.59%-306.68K
-101.99%-3.34K
67.03%206.55K
Total composite income
-34.98%25.28M
-26.67%22.42M
-39.98%65.23M
-33.63%59.13M
-36.06%38.87M
-28.93%30.58M
-5.20%108.68M
1.19%89.09M
6.33%60.8M
10.03%43.03M
Total composite income of parent company owners
-34.98%25.28M
-26.67%22.42M
-39.98%65.23M
-33.63%59.13M
-36.06%38.87M
-28.93%30.58M
-5.20%108.68M
1.19%89.09M
6.33%60.8M
10.03%43.03M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -1.90%146.21M8.94%100.55M-23.07%270.4M-17.66%216.11M-12.57%149.04M-9.42%92.3M9.54%351.49M6.57%262.45M6.87%170.46M6.01%101.9M
Operating revenue -1.90%146.21M8.94%100.55M-23.07%270.4M-17.66%216.11M-12.57%149.04M-9.42%92.3M9.54%351.49M6.57%262.45M6.87%170.46M6.01%101.9M
Other operating revenue 5.26%57.5K-----1.33%114.97K-----0.40%54.63K----8.28%116.52K----7.12%54.84K----
Total operating cost 13.42%121.64M31.49%76.15M-11.51%203.77M-5.74%151.12M4.64%107.24M9.46%57.91M18.03%230.27M10.66%160.33M8.10%102.49M3.64%52.91M
Operating cost 21.98%96.5M39.32%62.81M-6.17%158.8M-1.20%118.61M1.99%79.11M3.32%45.09M19.07%169.23M15.58%120.04M16.18%77.57M14.27%43.64M
Operating tax surcharges 38.40%2.33M45.75%1.65M2.40%4.36M-23.28%2.37M-13.20%1.68M-5.35%1.13M0.85%4.26M-1.98%3.08M-3.77%1.94M-1.46%1.19M
Operating expense -10.27%11.47M9.47%5.96M-21.59%26.45M-13.35%18.36M-12.31%12.78M-18.27%5.45M5.23%33.74M-1.22%21.18M-2.14%14.57M-0.53%6.66M
Administration expense -5.37%8.24M-7.16%3.68M3.84%17.92M2.13%13.09M0.74%8.71M2.38%3.96M-12.63%17.26M-3.56%12.82M-1.27%8.65M-1.81%3.87M
Financial expense -41.97%-3.86M-46.56%-1.89M-93.45%-18.89M-54.12%-13.07M64.32%-2.72M79.92%-1.29M41.16%-9.77M-34.18%-8.48M-89.33%-7.61M-169.55%-6.42M
-Interest Income (Financial expense) -41.80%-3.86M-46.48%-1.89M-----54.07%-13.08M64.24%-2.72M79.89%-1.29M-----34.11%-8.49M-89.15%-7.62M-169.29%-6.42M
Research and development -9.35%6.96M10.17%3.95M-2.67%15.13M0.75%11.76M4.08%7.67M-9.71%3.58M15.01%15.55M23.55%11.68M15.14%7.37M16.75%3.97M
Credit Impairment Loss -100.33%-1.98K-84.93%121.76K263.74%708.14K262.69%367.11K522.28%604.9K150.00%808.08K-366.27%-432.48K-31.76%-225.65K-39.99%97.21K-14.55%323.23K
Asset Impairment Loss 67.37%-197.91K-65.27%-377.44K-153.43%-503.34K-6.51%-483.94K-160.57%-606.47K-590.06%-228.37K68.20%-198.61K-75.57%-454.36K27.54%-232.75K75.09%-33.09K
Other net revenue 7.64%3.81M10.20%1.62M39.40%7.51M33.85%5.08M1.77%3.54M9.91%1.47M-20.77%5.38M-34.83%3.8M49.86%3.48M68.15%1.33M
Invest income 22.90%2.49M109.15%1.1M-5.63%4.07M3.78%3.17M-18.42%2.03M-13.19%523.93K-32.75%4.32M-39.40%3.06M61.38%2.48M517.74%603.53K
Asset deal income -621.97%-67.85K-621.97%-67.85K---290.57K--13K--13K--13K----------------
Other revenue 5.71%1.59M141.02%844.2K106.96%3.52M41.86%2.01M32.89%1.5M-20.57%350.26K9.42%1.7M17.42%1.42M20.10%1.13M-2.14%440.96K
Operating profit -37.39%28.38M-27.45%26.01M-41.45%74.13M-33.84%70.08M-36.55%45.33M-28.76%35.85M-4.51%126.6M-1.21%105.92M6.63%71.45M9.72%50.32M
Add:Non operating Income 3,662.18%300.97K2,255.93%188.47K123.09%31.24K-42.88%8K-42.88%8K-42.88%8K-60.34%14.01K-60.34%14.01K-60.34%14.01K--14.01K
Less:Non operating expense --6.7K--6.7K-1.06%1M-1.47%1M--------53.46%1.01M-73.55%1.01M--14.94K--1.04K
Total profit -36.75%28.68M-26.96%26.19M-41.75%73.16M-34.15%69.09M-36.54%45.34M-28.76%35.86M-4.82%125.6M1.46%104.92M6.57%71.45M9.74%50.34M
Less:Income tax cost -53.41%3.17M-37.93%3.36M-47.54%8.8M-33.09%10.39M-36.09%6.8M-28.00%5.41M-5.06%16.78M0.56%15.52M6.16%10.65M9.17%7.52M
Net profit -33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M9.85%42.82M
Net profit from continuing operation -33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M9.85%42.82M
Net profit of parent company owners -33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M9.85%42.82M
Earning per share
Basic earning per share -33.33%0.16-26.32%0.14-41.18%0.4-33.93%0.37-36.84%0.24-29.63%0.19-4.23%0.681.82%0.565.56%0.3812.50%0.27
Diluted earning per share -33.33%0.16-26.32%0.14-41.18%0.4-33.93%0.37-36.84%0.24-29.63%0.19-4.23%0.681.82%0.565.56%0.3812.50%0.27
Other composite income -169.19%-231.39K-404.10%-407.24K705.96%869.74K240.11%429.7K10,126.03%334.44K-35.17%133.92K-140.55%-143.53K-562.59%-306.68K-101.99%-3.34K67.03%206.55K
Other composite income of parent company owners -169.19%-231.39K-404.10%-407.24K705.96%869.74K240.11%429.7K10,126.03%334.44K-35.17%133.92K-140.55%-143.53K-562.59%-306.68K-101.99%-3.34K67.03%206.55K
Total composite income -34.98%25.28M-26.67%22.42M-39.98%65.23M-33.63%59.13M-36.06%38.87M-28.93%30.58M-5.20%108.68M1.19%89.09M6.33%60.8M10.03%43.03M
Total composite income of parent company owners -34.98%25.28M-26.67%22.42M-39.98%65.23M-33.63%59.13M-36.06%38.87M-28.93%30.58M-5.20%108.68M1.19%89.09M6.33%60.8M10.03%43.03M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data